US 12064507
Composition and method for oral treatment of leukemia
granted A61KA61K31/352A61K31/4035
Quick answer
US patent 12064507 (Composition and method for oral treatment of leukemia) held by Provectus Pharmatech, Inc. expires Mon Aug 15 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Provectus Pharmatech, Inc.
- Grant date
- Tue Aug 20 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 15 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 27
- CPC classes
- A61K, A61K31/352, A61K31/4035, A61K31/519, A61K31/522